Frequencies of antigen expression at diagnosis and relapse and of antigen loss and gain at relapse
| Antigen . | N3-150 . | Expressed at diagnosis . | Lost at relapse3-151 . | Gained at relapse3-152 . | Expressed at relapse . | P3-153 . |
|---|---|---|---|---|---|---|
| CD2 | 126 | 14 (11) | 2 (14) | 16 (14) | 28 (22) | .001 |
| CD3 | 129 | 3 (2) | 3 (100) | 0 (0) | 0 (0) | — |
| CD4dim | 129 | 93 (72) | 5 (5) | 13 (36) | 101 (78) | .10 |
| CD7 | 126 | 28 (22) | 3 (11) | 13 (13) | 38 (30) | .02 |
| CD8 | 128 | 1 (1) | 1 (100) | 6 (5) | 6 (5) | .13 |
| CD11b | 126 | 52 (41) | 14 (27) | 9 (12) | 47 (37) | .21 |
| CD13 | 132 | 129 (98) | 3 (2) | 2 (67) | 128 (97) | .38 |
| CD14 | 129 | 16 (12) | 6 (38) | 0 (0) | 10 (8) | < .001 |
| CD15 | 127 | 104 (82) | 11 (11) | 6 (26) | 99 (78) | .14 |
| CD16 | 122 | 3 (2) | 2 (67) | 3 (3) | 4 (3) | 1.00 |
| CD19 | 98 | 5 (5) | 2 (40) | 5 (5) | 8 (8) | .45 |
| CD32 | 122 | 93 (76) | 11 (12) | 8 (28) | 90 (74) | .36 |
| CD33 | 130 | 97 (75) | 10 (10) | 15 (45) | 102 (78) | .42 |
| CD34 | 129 | 82 (64) | 3 (4) | 17 (36) | 96 (74) | .003 |
| CD38 | 83 | 80 (96) | 3 (4) | 1 (33) | 78 (94) | .13 |
| CD56 | 121 | 20 (17) | 8 (40) | 14 (14) | 26 (21) | .29 |
| CD64 | 122 | 61 (50) | 16 (26) | 10 (16) | 55 (45) | .17 |
| HLADr | 132 | 100 (76) | 6 (6) | 5 (16) | 99 (74) | .55 |
| Antigen . | N3-150 . | Expressed at diagnosis . | Lost at relapse3-151 . | Gained at relapse3-152 . | Expressed at relapse . | P3-153 . |
|---|---|---|---|---|---|---|
| CD2 | 126 | 14 (11) | 2 (14) | 16 (14) | 28 (22) | .001 |
| CD3 | 129 | 3 (2) | 3 (100) | 0 (0) | 0 (0) | — |
| CD4dim | 129 | 93 (72) | 5 (5) | 13 (36) | 101 (78) | .10 |
| CD7 | 126 | 28 (22) | 3 (11) | 13 (13) | 38 (30) | .02 |
| CD8 | 128 | 1 (1) | 1 (100) | 6 (5) | 6 (5) | .13 |
| CD11b | 126 | 52 (41) | 14 (27) | 9 (12) | 47 (37) | .21 |
| CD13 | 132 | 129 (98) | 3 (2) | 2 (67) | 128 (97) | .38 |
| CD14 | 129 | 16 (12) | 6 (38) | 0 (0) | 10 (8) | < .001 |
| CD15 | 127 | 104 (82) | 11 (11) | 6 (26) | 99 (78) | .14 |
| CD16 | 122 | 3 (2) | 2 (67) | 3 (3) | 4 (3) | 1.00 |
| CD19 | 98 | 5 (5) | 2 (40) | 5 (5) | 8 (8) | .45 |
| CD32 | 122 | 93 (76) | 11 (12) | 8 (28) | 90 (74) | .36 |
| CD33 | 130 | 97 (75) | 10 (10) | 15 (45) | 102 (78) | .42 |
| CD34 | 129 | 82 (64) | 3 (4) | 17 (36) | 96 (74) | .003 |
| CD38 | 83 | 80 (96) | 3 (4) | 1 (33) | 78 (94) | .13 |
| CD56 | 121 | 20 (17) | 8 (40) | 14 (14) | 26 (21) | .29 |
| CD64 | 122 | 61 (50) | 16 (26) | 10 (16) | 55 (45) | .17 |
| HLADr | 132 | 100 (76) | 6 (6) | 5 (16) | 99 (74) | .55 |
Number of cases studied for the antigen on the same population both at diagnosis and at relapse.
Number (percentage) of cases with antigen expression at diagnosis which lost expression of the antigen at relapse.
Number (percentage) of cases without antigen expression at diagnosis which gained expression of the antigen at relapse.
McNemar test of proportions for paired data.